Search Results - "ASHCRAFT, Deborah"

Refine Results
  1. 1

    Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii by Thomas, Varsha M., Brown, Ryan M., Ashcraft, Deborah S., Pankey, George A.

    “…•New antimicrobials are needed for carbapenem-resistant Acinetobacter baumannii.•Nisin is an FDA-approved antibacterial peptide currently used as a food…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Fracture Resistance of Titanium‐Based Lithium Disilicate and Zirconia Implant Restorations by Roberts, Evan E., Bailey, Clifton W., Ashcraft‐Olmscheid, Deborah L., Vandewalle, Kraig S.

    Published in Journal of prosthodontics (01-08-2018)
    “…Purpose To evaluate the fracture resistance of a newer lithium disilicate abutment material. Materials and Methods A premolar‐shaped implant crown was designed…”
    Get full text
    Journal Article
  4. 4

    Evaluation of the in vitro interaction of fosfomycin and meropenem against metallo-β-lactamase–producing Pseudomonas aeruginosa using Etest and time-kill assay by Jahan, Sanjida, Davis, Heather, Ashcraft, Deborah S, Pankey, George A

    Published in Journal of investigative medicine (01-02-2021)
    “…Pseudomonas aeruginosa is a nosocomial pathogen containing various resistance mechanisms. Among them, metallo-β-lactamase (MBL)–producing Pseudomonas are…”
    Get full text
    Journal Article
  5. 5

    In vitro interaction of fluconazole and trimethoprim–sulfamethoxazole against Candida auris using ETEST and checkerboard methods by Davis, Heather R, Ashcraft, Deborah S, Pankey, George A

    Published in Journal of investigative medicine (01-01-2021)
    “…Candida auris was discovered in 2009 and has rapidly emerged as a serious public health threat with cases reported in over 20 countries worldwide. As of May 8,…”
    Get full text
    Journal Article
  6. 6

    In vitro synergy with fosfomycin plus doxycyclin against linezolid and vancomycin-resistant Enterococcus faecium by Davis, Heather, Brown, Ryan, Ashcraft, Deborah, Pankey, George

    “…•Enterococcus is the second leading cause of health care–associated infections.•Linezolid resistance in vancomycin-resistant enterococci (VRE) is…”
    Get full text
    Journal Article
  7. 7

    Comparison of 3 Etest® methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species by Pankey, George A, Ashcraft, Deborah S, Dornelles, Adriana

    “…Abstract Increasing global antibiotic resistance has resulted in more use of antibiotic combinations. There is a lack of a gold standard for in vitro testing…”
    Get full text
    Journal Article
  8. 8
  9. 9

    In vitro synergy with fluconazole plus doxycycline or tigecycline against clinical Candida glabrata isolates by Hooper, Randol W, Ashcraft, Deborah S, Pankey, George A

    Published in Medical mycology (Oxford) (01-01-2019)
    “…Abstract Candida species, traditionally viewed as opportunistic agents, are increasingly seen as a cause of infection in hospitalized patients. Treatment…”
    Get full text
    Journal Article
  10. 10

    Genetic Divergence of Vibrio vulnificus Clinical Isolates with Mild to Severe Outcomes by Kling, Kendall, Trinh, Sonya A, Leyn, Semen A, Rodionov, Dmitry A, Rodionov, Ivan D, Herrera, Alfa, Cervantes, Kasey, Pankey, George, Ashcraft, Deborah, Ozer, Egon A, Godzik, Adam, Satchell, Karla J F

    Published in mBio (26-10-2022)
    “…The marine bacterium Vibrio vulnificus infects humans via food or water contamination, leading to serious manifestations, including gastroenteritis, wound…”
    Get full text
    Journal Article
  11. 11

    In vitro Synergistic Activity of Caspofungin Plus Polymyxin B Against Fluconazole-Resistant Candida glabrata by Adams, Emily K., MS, Ashcraft, Deborah S., MT, Pankey, George A., MD

    “…Abstract Background Candida species account for most invasive fungal infections, and the emergence of fluconazole and caspofungin resistance is problematic…”
    Get full text
    Journal Article
  12. 12

    Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae by Pankey, George A, Ashcraft, Deborah S

    “…Abstract Polymyxin B (PB) plus meropenem (MER) or rifampin (RIF) was tested by Etest® method and time-kill assay (TKA) against 14 genetically unique clinical…”
    Get full text
    Journal Article
  13. 13
  14. 14

    In Vitro Synergy of Ciprofloxacin and Gatifloxacin against Ciprofloxacin-Resistant Pseudomonas aeruginosa by PANKEY, George A, ASHCRAFT, Deborah S

    Published in Antimicrobial Agents and Chemotherapy (01-07-2005)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  15. 15

    In Vitro Synergy of Daptomycin plus Rifampin against Enterococcus faecium Resistant to both Linezolid and Vancomycin by PANKEY, George, ASHCRAFT, Deborah, PATEL, Nalini

    Published in Antimicrobial Agents and Chemotherapy (01-12-2005)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  16. 16

    The detection of synergy between meropenem and polymyxin B against meropenem-resistant Acinetobacter baumannii using Etest® and time-kill assay by Pankey, George A, Ashcraft, Deborah S

    “…Abstract Time-kill assay and Etest testing for synergy of meropenem (MER) (1× MIC) plus polymyxin B (1/4, 1/2, and 1× MIC) were performed against 8 genetically…”
    Get full text
    Journal Article
  17. 17

    In vitro antibacterial activity of tigecycline against resistant Gram-negative bacilli and enterococci by time–kill assay by Pankey, George A, Ashcraft, Deborah S

    “…Abstract This time–kill study was performed with 65 genetically unique clinical isolates of Gram-negative bacilli and enterococci to further define the…”
    Get full text
    Journal Article
  18. 18

    In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia by Pankey, George A, Ashcraft, Deborah S

    “…Abstract Synergy testing of levofloxacin and meropenem by Etest and time–kill assay (TKA) was performed against 30 genetically unique clinical Stenotrophomonas…”
    Get full text
    Journal Article
  19. 19

    In Vitro Synergy of Telavancin and Rifampin Against Enterococcus faecium Resistant to Both Linezolid and Vancomycin by Pankey, George A, Ashcraft, Deborah S

    Published in The Ochsner journal (2013)
    “…An emerging pathogen is Enterococcus faecium resistant to both linezolid and vancomycin (LRVRE). Antimicrobial combinations may be required for therapy and…”
    Get full text
    Journal Article
  20. 20

    Bacteremia Due to Bacteroides fragilis Group: Distribution of Species, β-Lactamase Production, and Antimicrobial Susceptibility Patterns by ALDRIDGE, Kenneth E, ASHCRAFT, Deborah, O'BRIEN, Megan, SANDERS, Charles V

    Published in Antimicrobial Agents and Chemotherapy (01-01-2003)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article